admin

/Angie Nance
­

About Angie Nance

This author has not yet filled in any details.
So far Angie Nance has created 17 blog entries.

WellPoint, Inc. acquires Amerigroup Corp.

Atlanta Business Chronicle by Carla Caldwell, Morning Call Editor Date: Tuesday, December 25, 2012, 6:11am EST - Last Modified: Tuesday, December 25, 2012, 8:48am EST WellPoint, Inc., (NYSE: WLP) has completed its acquisition of Amerigroup Corporation (NYSE: AGP), WellPoint announced Monday. “By leveraging our combined clinical capabilities, resources and expertise, WellPoint’s competitive position in the Dual [...]

By |December 26th, 2012|Uncategorized|0 Comments

Ultragenyx, Led by BioMarin Vet, Snags $75M for Ultra-Rare Diseases

Luke Timmerman12/20/12 Some of the biggest investment checks in biotech are going to startups focused on treating extremely tiny groups of patients. You can see the story playing out at a little company in Novato, CA, called Ultragenyx Pharmaceutical. The company, founded by former BioMarin Pharmaceuticals executive Emil Kakkis in April 2010, is announcing today [...]

By |December 20th, 2012|Uncategorized|0 Comments

Where E.R. Doctors Work Entirely Via Skype

Dec 11 2012, 8:06 AM ET In South Dakota, long-distance doctoring is bringing health care to rural communities. Every day -- and through the night -- in Sioux Falls, South Dakota, doctors report to work in a hospital where there are no patients. And in over 70 rural communities in four states, patients stricken by [...]

By |December 11th, 2012|Uncategorized|0 Comments

Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules

NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for tacrolimus extended release capsules, for the prophylaxis of organ rejection in adult [...]

By |December 6th, 2012|Uncategorized|0 Comments

Physicians Interactive Acquires InfoMedics

Latest Move Marks Major Expansion for Physicians Interactive Into Patient Healthcare Communication and Medication Adherence  

By |December 3rd, 2012|Uncategorized|0 Comments

NextGen, Microsoft to launch mobile personal medication record

Seek to drive patient engagement with mobile meds management HORSHAM, PA | November 26, 2012 NextGen Healthcare Information Systems is partnering with Microsoft to offer a mobile app for the Windows 8 platform that enables consumers to create, store, track and share personal medication records. NextGen and Microsoft officials say the MedicineCabinet app, available for [...]

By |November 27th, 2012|Uncategorized|0 Comments

Healthrageous gets Partners financing, sees progress on hypertension biofeedback

Latest round of funding will go toward machine learning technology BOSTON | November 27, 2012 Healthrageous, which develops technology for health self-management, has received $700,000 in Series B financing from the Partners HealthCare Innovation Fund --close on the heels of a $6.5 million round of financing from other investors in October. "They originally created us, [...]

By |November 27th, 2012|Uncategorized|0 Comments

Novartis says may have 14 new blockbuster drugs by 2017

By Caroline Copley, Reuters Nov. 08, 2012 5:31AM PSTNov. 08, 2012 5:31AM PST ZURICH (Reuters) - Novartis could produce 14 or more new big-selling 'blockbuster' drugs within five years as it bets on cancer, heart and respiratory treatments to fill the gaps left by expiries on current patents, the Swiss firm said on Thursday. Like [...]

By |November 9th, 2012|Uncategorized|0 Comments

Imaging market set to grow, slowly, to $4.5B by 2017

November 06, 2012 | Mike Miliard, Managing Editor TORONTO – Even as reimbursement cuts and radiation dosing concerns have helped put the brakes on its growth, an increase in procedure volume will see the U.S. diagnostic imaging system market increase to roughly $4.5 billion through 2017, according to Millennium Research Group (MRG). In its report, [...]

By |November 8th, 2012|Uncategorized|0 Comments

Israeli medical device offers new Alzheimer’s treatment

By Tova Cohen, Reuters Oct. 24, 2012 5:05AM PDTOct. 24, 2012 5:05AM PDT TEL AVIV (Reuters) - Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014. The device, which combines electromagnetic stimulation with [...]

By |October 24th, 2012|Uncategorized|0 Comments